3D Printing Group

Created by Abe Gladstone on 15 February, 2018

3D Bioprinting refers to the three-dimensional printing of a biological tissue and organ done with the help of living cells, through organ transplantation and tissue engineering. It mainly utilizes layer-by-layer method, computed tomography (CT) and magnetic resonance imaging (MRI) techniques. 3D Bioprinting is used to print tissues and organs that helps during drug and pills research and has also begun to include the printing of scaffolds that can be used to regenerate joints and ligaments.

The medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of 3D Bioprinting market with detailed market segmentation by type, technology, application and geography. The global 3D Bioprinting market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading 3D Bioprinting market players and offers key trends and opportunities in the market.

The global 3D Bioprinting market is segmented on the basis of type, technology and application. Based on type the market is segmented into organ transplantation, tissue engineering. Based on technology the market is segmented into inkjet based, laser based, extrusion based, magnetic. Based on application the market is segmented into clinical application, research application.

Leading companies such as

  •  Nano3D Biosciences, Inc
  •  Envisiontec GmbH
  •  Organovo Holdings, Inc
  •  Cyfuse Biomedical K.K
  •  Regenhu Ltd
  •  Aspect Biosystems Ltd
  •  Cellink AB
  •  Regenovo Biotechnology Co., Ltd
  •  3Dynamic Systems Ltd.,
  •  Poietis

Download PDF Brochure of study https://bit.ly/3j4fbpv